Seawater-immersed wounds
For empirical therapy for localised infection of seawater-immersed wounds (including coral cuts) not associated with systemic features or involving deeper tissues, use:
doxycycline orally, 12-hourly1 doxycycline doxycycline doxycycline
adult: 100 mg
child less than 21 kg: 2.2 mg/kg2
child 21 to less than 26 kg: 50 mg
child 26 to 35 kg: 75 mg
child more than 35 kg: 100 mg
PLUS EITHER
1dicloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see dicloxacillin dosage adjustment dicloxacillin dicloxacillin dicloxacillin
OR
1flucloxacillin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see flucloxacillin oral dosage adjustment. flucloxacillin flucloxacillin flucloxacillin
For children who cannot take doxycycline, use:
ciprofloxacin 12.5 mg/kg up to 500 mg orally, 12-hourly34. For dosage adjustment in adults with kidney impairment, see ciprofloxacin oral dosage adjustment. ciprofloxacin ciprofloxacin ciprofloxacin
Cefalexin is often preferred to dicloxacillin or flucloxacillin in children because the liquid formulation is better tolerated. It can also be used for patients who have had a nonsevere (immediate or delayed) hypersensitivity reaction to a penicillin5, use:
1cefalexin 500 mg (child: 12.5 mg/kg up to 500 mg) orally, 6-hourly. For dosage adjustment in adults with kidney impairment, see cefalexin dosage adjustment cefalexin cefalexin cefalexin
OR if adherence to a 6-hourly regimen is unlikely in a child
1cefalexin 20 mg/kg up to 750 mg orally, 8-hourly6. cefalexin cefalexin cefalexin
For patients at increased risk of MRSA infection (see Risk factors for infection with methicillin-resistant Staphylococcus aureus), trimethoprim+sulfamethoxazole can be used in place of the above regimens. Use:
trimethoprim+sulfamethoxazole 320+1600 mg (child 1 month or over: 8+40 mg/kg up to 320+1600 mg) orally, 12-hourly. For dosage adjustment in adults with kidney impairment, see trimethoprim+sulfamethoxazole dosage adjustment. trimethoprim + sulfamethoxazole trimethoprim+sulfamethoxazole trimethoprim+sulfamethoxazole
Modify therapy based on the results of culture and susceptibility testing; see Aeromonas species, Vibrio species and Mycobacterium marinum.
If a pathogen is not identified, the duration of therapy is determined by clinical response. A duration of 5 days is likely to be appropriate.
